ISSN: 2161-1068
+44 1478 350008
Sanjukta Patra
Indian Institute of Technology,
Guwahati - 781039, Assam
India
Short Communication
Rv3802c in Tuberculosis Therapeutics
Author(s): Parameswaran Saravanan and Sanjukta PatraParameswaran Saravanan and Sanjukta Patra
The recent upsurge of life-threatening multidrug- and extreme drug- resistant tuberculosis along with HIV co-infection urge the need of new drug targets and drugs to cripple the survival and infection of Mycobacterium tuberculosis. The current scenario of tuberculosis might be dealt by targeting pathogen’s enzymes that participate in both cell wall and lipid metabolism... View More»
DOI:
10.4172/2161-1068.1000204